Cargando…
Update on transfusion-related acute lung injury: an overview of its pathogenesis and management
Transfusion-related acute lung injury (TRALI) is a severe adverse event and a leading cause of transfusion-associated death. Its poor associated prognosis is due, in large part, to the current dearth of effective therapeutic strategies. Hence, an urgent need exists for effective management strategie...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213666/ https://www.ncbi.nlm.nih.gov/pubmed/37251400 http://dx.doi.org/10.3389/fimmu.2023.1175387 |
_version_ | 1785047673379749888 |
---|---|
author | Yu, Yunhong Lian, Zhengqiu |
author_facet | Yu, Yunhong Lian, Zhengqiu |
author_sort | Yu, Yunhong |
collection | PubMed |
description | Transfusion-related acute lung injury (TRALI) is a severe adverse event and a leading cause of transfusion-associated death. Its poor associated prognosis is due, in large part, to the current dearth of effective therapeutic strategies. Hence, an urgent need exists for effective management strategies for the prevention and treatment of associated lung edema. Recently, various preclinical and clinical studies have advanced the current knowledge regarding TRALI pathogenesis. In fact, the application of this knowledge to patient management has successfully decreased TRALI-associated morbidity. This article reviews the most relevant data and recent progress related to TRALI pathogenesis. Based on the existing two-hit theory, a novel three-step pathogenesis model composed of a priming step, pulmonary reaction, and effector phase is postulated to explain the process of TRALI. TRALI pathogenesis stage-specific management strategies based on clinical studies and preclinical models are summarized with an explication of their models of prevention and experimental drugs. The primary aim of this review is to provide useful insights regarding the underlying pathogenesis of TRALI to inform the development of preventive or therapeutic alternatives. |
format | Online Article Text |
id | pubmed-10213666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102136662023-05-27 Update on transfusion-related acute lung injury: an overview of its pathogenesis and management Yu, Yunhong Lian, Zhengqiu Front Immunol Immunology Transfusion-related acute lung injury (TRALI) is a severe adverse event and a leading cause of transfusion-associated death. Its poor associated prognosis is due, in large part, to the current dearth of effective therapeutic strategies. Hence, an urgent need exists for effective management strategies for the prevention and treatment of associated lung edema. Recently, various preclinical and clinical studies have advanced the current knowledge regarding TRALI pathogenesis. In fact, the application of this knowledge to patient management has successfully decreased TRALI-associated morbidity. This article reviews the most relevant data and recent progress related to TRALI pathogenesis. Based on the existing two-hit theory, a novel three-step pathogenesis model composed of a priming step, pulmonary reaction, and effector phase is postulated to explain the process of TRALI. TRALI pathogenesis stage-specific management strategies based on clinical studies and preclinical models are summarized with an explication of their models of prevention and experimental drugs. The primary aim of this review is to provide useful insights regarding the underlying pathogenesis of TRALI to inform the development of preventive or therapeutic alternatives. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213666/ /pubmed/37251400 http://dx.doi.org/10.3389/fimmu.2023.1175387 Text en Copyright © 2023 Yu and Lian https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yu, Yunhong Lian, Zhengqiu Update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
title | Update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
title_full | Update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
title_fullStr | Update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
title_full_unstemmed | Update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
title_short | Update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
title_sort | update on transfusion-related acute lung injury: an overview of its pathogenesis and management |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213666/ https://www.ncbi.nlm.nih.gov/pubmed/37251400 http://dx.doi.org/10.3389/fimmu.2023.1175387 |
work_keys_str_mv | AT yuyunhong updateontransfusionrelatedacutelunginjuryanoverviewofitspathogenesisandmanagement AT lianzhengqiu updateontransfusionrelatedacutelunginjuryanoverviewofitspathogenesisandmanagement |